Risk factors of progression from discoid lupus to severe systemic lupus erythematosus: a registry-based cohort study of 164 patients.

被引:7
作者
Fredeau, Lisa [1 ]
Courvoisier, Delphine S. [2 ]
Mehdi, Raphael Ait [3 ]
Ingen-Housz-Oro, Saskia [4 ]
Mahe, Emmanuel [5 ]
Costedoat-Chalumeau, Nathalie [6 ]
Arnaud, Laurent [7 ]
Frances, Camille [1 ]
Mathian, Alexis [8 ]
Jachiet, Marie [9 ]
Amoura, Zahir [9 ]
Bouaziz, Jean David [9 ]
Chasset, Francois [9 ]
机构
[1] Sorbonne Univ, Hop Tenon, AP HP, Serv Dermatol & Allergol,Fac Med, Paris, France
[2] Hop Univ Geneve, Serv Epidemiol Clin, Geneva, Switzerland
[3] Grand Hop Est Francilien, Serv Dermatol, Jossigny, France
[4] Univ Paris Est Creteil EpidermE, Hop Mondor, AP HP, Serv Dermatol, Creteil, France
[5] Ctr Hosp Victor Dupuy, Serv Dermatol, Argenteuil, France
[6] Univ Paris, Hop Cochin, AP HP, Serv Med Interne,Fac Med, Paris, France
[7] Univ Strasbourg, Hop Univ Strasbourg, Ctr Natl References Malad Syst & Autoimmunes Rare, Serv Rhumatol, Strasbourg, France
[8] Sorbonne Univ, Grp Hosp Pitie Salpetriere, AP HP, Ctr Natl Reference lupus Syst Syndrome Antiphos P, Paris, France
[9] Univ Paris, Hop St Louis, AH HP, Serv Dermatol,Fac Med, Paris, France
关键词
cutaneous lupus erythematosus; evolution; predictive score; progression; risk factors; severe systemic lupus erythematosus; CLASSIFICATION; FEATURES;
D O I
10.1016/j.jaad.2022.09.028
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: No study has assessed the risk factors of progression from discoid lupus erythematosus (DLE) to severe systemic lupus erythematosus (sSLE) (defined as requiring hospitalization and specific treatment).Objective: To identify the risks factors of and generate a predicting score for progression to sSLE among patients with isolated DLE or associated with systemic lupus erythematosus with mild biological abnormalities.Methods: In this registry-based cohort study, multivariable analysis was performed using risk factors identified from literature and pruned by backward selection to identify relevant variables. The number of points was weighted proportionally to the odds ratio (OR).Results: We included 30 patients with DLE who developed sSLE and 134 patients who did not. In multivariable analysis, among 12 selected variables, an age of <25 years at the time of DLE diagnosis (OR, 2.8; 95% CI, 1.1-7.0; 1 point), phototype V to VI (OR, 2.7; 95% CI, 1.1-7.0; 1 point), and antinuclear antibody titers of >= 1:320 (OR, 15; 95% CI, 3.3-67.3; 5 points) were selected to generate the score. Among the 54 patients with a score of 0 at baseline, none progressed to sSLE, whereas a score of >= 6 was associated with a risk of approximately 40%.Limitations: Retrospective design.Conclusion: In our cohort, an age of <25 years at the time of DLE diagnosis, phototype V to VI, and antinuclear antibody titers of >= 1:320 were risk factors for developing sSLE. ( J Am Acad Dermatol 2023;88:551-9.)
引用
收藏
页码:551 / 559
页数:9
相关论文
共 50 条
  • [41] Organ Damage and Its Associated Factors in Systemic Lupus Erythematosus Patients: A Retrospective Cohort Study
    Alharbi, Lujain K.
    Al-Homood, Ibrahim A.
    Binammar, Ammar A.
    Almuhareb, Nojoud M.
    JOURNAL OF CLINICAL MEDICINE RESEARCH-CANADA, 2025, 17 (01): : 35 - 43
  • [42] Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study
    Gustafsson, Johanna
    Gunnarsson, Iva
    Borjesson, Ola
    Pettersson, Susanne
    Moller, Sonia
    Fei, Guo-Zhong
    Elvin, Kerstin
    Simard, Julia F.
    Hansson, Lars-Olof
    Lundberg, Ingrid E.
    Larsson, Anders
    Svenungsson, Elisabet
    ARTHRITIS RESEARCH & THERAPY, 2009, 11 (06)
  • [43] Incidence, associated factors and clinical impact of severe infections in a large, multicentric cohort of patients with systemic lupus erythematosus
    Rua-Figueroa, Inigo
    Lopez-Longo, Javier
    Galindo-Izquierdo, Maria
    Calvo-Alen, Jaime
    Del Campo, Victor
    Olive-Marques, Alejandro
    Perez-Vicente, Sabina
    Fernandez-Nebro, Antonio
    Andres, Mariano
    Erausquin, Celia
    Tomero, Eva
    Horcada, Loreto
    Uriarte, Esther
    Freire, Mercedes
    Montilla, Carlos
    Sanchez-Atrio, Ana
    Santos, Gregorio
    Boteanu, Alina
    Diez-Alvarez, Elvira
    Narvaez, Javier
    Martinez-Taboada, Victor
    Silva-Fernandez, Lucia
    Ruiz-Lucea, Esther
    Luis Andreu, Jose
    Angel Hernandez-Beriain, Jose
    Gantes, Marian
    Hernandez-Cruz, Blanca
    Perez-Venegas, Jose
    Pecondon-Espanol, Angela
    Marras, Carlos
    Ibanez-Barcelo, Monica
    Bonilla, Gema
    Torrente, Vicente
    Castellvi, Ivan
    Jose Alegre, Juan
    Calvet, Joan
    Luis Marenco, Jose
    Raya, Enrique
    Vazquez, Tomas
    Quevedo, Victor
    Munoz-Fernandez, Santiago
    Rodriguez-Gomez, Manuel
    Ibanez, Jesus
    Pego-Reigosa, Jose M.
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2017, 47 (01) : 38 - 45
  • [44] The prevalence and risk factors for serositis in patients with systemic lupus erythematosus: a cross-sectional study
    Liang, Yan
    Leng, Rui-Xue
    Pan, Hai-Feng
    Ye, Dong-Qing
    RHEUMATOLOGY INTERNATIONAL, 2017, 37 (02) : 305 - 311
  • [45] The characteristics and risk factors of cerebrovascular events in young systemic lupus erythematosus patients: A case-control study
    Hsu, Uei-Hsiang
    Lin, Yu-Tsan
    Chiang, Bor-Luen
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (04) : 478 - 486
  • [46] Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus
    Mohammed Salah Eldin Abdelbaky
    Tarek Ahmad El Mamoun
    Fatma Ibrahim Mabrouk
    Rasha Mohamad Hassan
    The Egyptian Journal of Internal Medicine, 2021, 33
  • [47] Risk factors of disease activity and renal damage in patients with systemic lupus erythematosus
    Feng, Huiling
    Lu, Qianyu
    Liu, Yi
    Shi, Mengmeng
    Lian, Huan
    Ni, Lihua
    Wu, Xiaoyan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (12) : 3845 - 3855
  • [48] Risk Factors for Clinical Coronary Heart Disease in Systemic Lupus Erythematosus: The Lupus and Atherosclerosis Evaluation of Risk (LASER) Study
    Haque, Sahena
    Gordon, Caroline
    Isenberg, David
    Rahman, Anisur
    Lanyon, Peter
    Bell, Aubrey
    Emery, Paul
    McHugh, Neil
    Teh, Lee Suan
    Scott, David G. I.
    Akil, Mohamed
    Naz, Sophia
    Andrews, Jacqueline
    Griffiths, Bridget
    Harris, Helen
    Youssef, Hazem
    McLaren, John
    Toescu, Veronica
    Devakumar, Vinodh
    Teir, Jamal
    Bruce, Ian N.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (02) : 322 - 329
  • [49] Neuro-psychiatric manifestations in patients with systemic lupus erythematosus: A systematic review and results from the Swiss lupus cohort study
    Meier, Aline L.
    Bodmer, Nicolas S.
    Wirth, Carla
    Bachmann, Lucas M.
    Ribi, Camillo
    Probstel, Anne-Katrin
    Waeber, David
    Jelcic, Ilijas
    Steiner, Urs C.
    LUPUS, 2021, 30 (10) : 1565 - 1576
  • [50] Risk factors for mortality in 1528 Brazilian childhood-onset systemic lupus erythematosus patients
    Sakamoto, Ana P.
    Silva, Clovis A.
    Pita, Ana C.
    Trindade, Vitor C.
    Islabao, Aline G.
    Fiorot, Fernanda J.
    Lopes, Sandra R. M.
    Pereira, Rosa M. R.
    Saad-Magalhaes, Claudia
    Russo, Gleice C. S.
    Len, Claudio A.
    do Prado, Rogerio
    Campos, Lucia M. A.
    Aikawa, Nadia E.
    Appenzeller, Simone
    Ferriani, Virginia P. L.
    Silva, Marco F.
    Felix, Marta
    Fonseca, Adriana R.
    Assad, Ana P. L.
    Sztajnbok, Flavio R.
    Santos, Maria C.
    Bica, Blanca E.
    Sena, Evaldo G.
    Moraes, Ana J.
    Fraga, Melissa M.
    Robazzi, Teresa C.
    Spelling, Paulo F.
    Scheibel, Iloite M.
    Cavalcanti, Andre S.
    Matos, Erica N.
    Guimaraes, Luciano J.
    Santos, Flavia P.
    Mota, Licia M. H.
    Bonfa, Eloisa
    Terreri, Maria T.
    LUPUS, 2023, 32 (06) : 781 - 790